Abstract:During our life, we are surrounded by continuous threats from a diverse range of invading pathogens. Our immune system has evolved multiple mechanisms to efficiently deal with these threats so as to prevent them from causing disease. Terminal differentiation of mature B cells into plasma cells (PC) - the antibody (Ab) secreting cells of the immune system - is critical for the generation of protective and long-lived humoral immune responses. Indeed, efficient production of antigen (Ag)-specific Ab by activated B cells underlies the success of most currently available vaccines. The mature B-cell pool is composed of several subsets, distinguished from one according to size, surface marker expression, location, and Ag exposure, and they all have the capacity to differentiate into PCs. For a B-cell to acquire the capacity to produce Abs, it must undergo an extensive differentiation process driven by changes in gene expression. Two broad categories of Ags exist that cause B-cell activation and differentiation: T cell dependent (TD) or T cell independent (TI). In addition to the B-cell subset and nature of the Ag, it is important to consider the cytokine environment that can also influence how B-cell differentiation is achieved. Thus, while many cytokines can induce Ab-secretion by B cells after activation with mimics of TD and TI stimuli in vitro, they can have different efficacies and specificities, and can often preferentially induce production of one particular Ig isotype over another. Here, we will provide an overview of in vitro studies (mouse and human origin) that evaluated the role of different cytokines in inducing the differentiation of distinct B-cell subsets to the PC lineage. We will place particular emphasis on IL-21, which has emerged as the most potent inducer of terminal B-cell differentiation in humans. We will also focus on the role of IL-21 and defects in B-cell function and how these contribute to human immunopathologies such as primary immunodeficiencies and B-cell mediated autoimmune conditions.

Cutting Edge: Importance of IL-6 and Cooperation between Innate and Adaptive Immune Receptors in Cellular Vaccination with B Lymphocytes1

IL-10 Augments Antibody Production Inin VitroImmunized Lymphocytes by Inducing a Th2-Type Response and B Cell Maturation

Cutting Edge: A Novel Mechanism Bridging Innate and Adaptive Immunity: IL-12 Induction of CD25 To Form High-Affinity IL-2 Receptors on NK Cells

Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

Exploiting Pre-Existing CD4<SUP>+</SUP> T Cell Help from Bacille Calmette-Guerin Vaccination to Improve Antiviral Antibody Responses

The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells

The Broad Immunomodulatory Effects of IL-7 and Its Application in Vaccines

Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients

Cutaneous vaccination with TLR2 agonists results in the suppression of Th1 responses

This Information is Current As MoleculesOrigin of the B-1 Cell Subset and B7 Immunity: an Evolutionary Perspective on Initiating APCs in Priming Adaptive B Cells in Teleost Fish Act As Pivotal

The role of lymphocyte subsets in preventing tuberculosis following intravenous vaccination with BCG

The Effects of CD40L on the Phenotypes and IL-12 Secretion of B Lymphocytes

Exploiting 4-1BB costimulation for enhancing antiviral vaccination

T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship

Ex vivo Model of Functioning Human Lymph Node Reveals Pivotal Role for Innate Lymphoid Cells and Stromal Populations in Response to Vaccine Adjuvant

IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation

Enhanced Protective Efficacy Against Mycobacterium Tuberculosis Afforded by BCG Prime‐dna Boost Regimen in an Early Challenge Mouse Model is Associated with Increased Splenic Interleukin‐2‐producing CD4 T‐cell Frequency Post‐vaccination

Steady-state, therapeutic, and helminth-induced IL-4 compromise protective CD8 T cell bystander activation

Differential recruitment and activation of mucosal and systemic ILC for improved vaccine design

A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity